SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (5564)2/20/1998 9:59:00 PM
From: RT  Read Replies (3) of 23519
 
TO ALL,

Tunica ,

I know I asked you to put a positive spin on what I thought was a low refill rate and your son (the math genius) comes up with 3.4 billion in sales after one year. WOW. Vivus needs to hire him as their new CFO.
Am I correct in assuming that the refill number is the total of all patients who have reordered the product more than once.. Of the 500,000 patients who ordered muse once, only 4,853 patients have reordered more than once this past week. Is that what this scrip data is telling us?

RT

PS. Where can we get a recap of the scrip data for the past year?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News